Skip to main content

Report on 414 Cases of Human Tumors Treated with Corynebacteria

  • Chapter
Corynebacterium Parvum

Abstract

Four-hundred and fourteen cases of human cancers in various clinical situations are reported. Randomized studies in advanced breast cancer and lung cancer, comparing combination chemotherapy with the same chemotherapy and weekly subcutaneous injections of Corynebacterium parvum, showed a significant superiority of the latter procedure in survival and resistance to bone-marrow depression and infections. Some uncontrolled studies showed an indication of synergism between C. parvum and BCG and a local effect of C. parvum injected intratumorally. Recent studies of C. parvum injected intravenously each day in a dose of 4 mg and without chemotherapy showed very promising and intriguing results in various disseminated cancers. Four good partial regressions were registered out of 12 patients. Problems relative to immune status and optimal conditions for nonspecific immune stimulation are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Dimitrov, N. V. (1975). In this volume.

    Google Scholar 

  • Halpern, B. N., Prévot, A. R., Biozzi, G., Stiffel, C., Mouton, D., Morard, J. C., Bouthillier, Y., and Decreusefond, C. (1964). Stimulation de l’activité phagocytaire du système réticuloendothélial provoquée par Corynebacterium parvum. J. Reticuloendothel. Soc. 1: 77–96.

    Google Scholar 

  • Halpern, B. N., Biozzi, G., Stiffel, C., and Mouton, D. (1966). Inhibition of tumor growth by administration of killed Corynebacterium parvum. Nature (Loud.) 212: 853–854.

    Article  CAS  Google Scholar 

  • Israel, L. (1973). Preliminary results of non-specific immunotherapy for lung cancer. Cancer Chemother. Rep. 4: 283–286.

    CAS  Google Scholar 

  • Israel, L. and Halpern, B. N. (1972). Le Corynebacterium parvum dans les cancers avancés. Première évaluation de l’activité thérapeutique de cette immunostimuline. Nouv. Presse Med. 1: 19–23.

    PubMed  CAS  Google Scholar 

  • Israel, L., Depierre, A., and Chahinian, P. (1971). Combination chemotherapy for 418 cases of advanced cancer. Cancer 27: 1089–1093.

    Article  PubMed  CAS  Google Scholar 

  • Israel, L., Depierre, A., and Edelstein, R. (1974). Local and systemic effects of intranodular BCG in 25 cases of recurrent melanoma. Proc. Am. Soc. Clin. Oncol. 15:161, Abstr. 711 (March 27–28).

    Google Scholar 

  • Paslin, D., Dimitrov, N. V., and Heaton, C. (1974). Regression of a transplantable hamster melanoma by intralesional injections of Corynebacterium granulosum. J. Natl. Cancer Inst. 52: 571.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Plenum Press, New York

About this chapter

Cite this chapter

Israel, L. (1975). Report on 414 Cases of Human Tumors Treated with Corynebacteria. In: Halpern, B. (eds) Corynebacterium Parvum. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4428-5_44

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-4428-5_44

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4430-8

  • Online ISBN: 978-1-4613-4428-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics